Zachary Dyer offers practical advice and solutions for insurance industry clients and other entities dealing with this highly specialized field. He represents the interests of insurance and reinsurance companies, producers, MGAs/MGUs and third-party administrators on a full range of corporate, transactional and regulatory matters including:

  • Multi-state insurance regulatory and corporate matters
  • InsurTech matters
  • Company formation, structuring, capitalization and licensure
  • Insurance Holding Company Act compliance
  • Mergers and acquisitions and joint ventures
  • Reinsurance arrangements and sales of blocks of business
  • Restructuring alternatives, including mutual holding company reorganizations and demutualizations
  • Product development and regulatory approval
  • Financial and market conduct examinations
  • Surplus lines matters

Zach also advises clients on the strategic design, formation, and implementation of alternative risk transfer structures, including captive insurance and reinsurance arrangements, risk retention groups (RRG) and risk purchasing groups (RPG).

Education

  • University of Kansas School of Law (J.D., 2007)
    • University of Kansas (M.S., 2004)
      • Education
    • University of Kansas (B.S., 2003)
      • Business Administration

    Bar Admission

    • Missouri, 2009

    Court Admissions

    • U.S. District Court, Western District of Missouri, 2009

    Professional Affiliations

    • The Missouri Bar
    • Kansas City Metropolitan Bar Association
    • American Bar Association
    • The American Health Law Association
    • The First Tee of Greater Kansas City
      • Board of Directors
    • University of Kansas K-Club Letterman's Association
    Publications
    All Publications
    Missouri Attorney General Files Suit Against Pharmacy Benefit Managers and Drug Manufacturers for Alleged Insulin Pricing Scheme
    Key Takeaways The Missouri AG filed suit in St. Louis County Circuit Court against several PBMs and drug manufacturers, alleging they conspired to manipulate Missouri’s health care market and unlawfully drive up insulin prices. The AG’s office seeks restitution and damages for affected consumers, injunctive relief to halt the alleged practices and a finding of unjust enrichment by the Defendants. Missouri Attorney General Catherine Hanaway recently filed suit against a number of Pharmacy Benefit Manager (PBM) companies and drug manufacturers (collectively, the Defendants) doing business in Missouri. According to the Missouri Attorney General's (AG) office, the Defendants have allegedly manipulated Missouri's health care markets, resulting in a significant increase in the price of insulin medication. The Missouri AG's lawsuit, filed in St. Louis County
    Read More
    Texas Regulatory Action Underscores Insurer Accountability for TPA Compliance
    Key Takeaways: A Florida-based insurer was recently fined by the Texas Department of Insurance for failing to ensure the competent administration of its programs by working with an unlicensed TPA and failing to conduct statutorily required semiannual reviews and biennial on-site audits of the TPA. The insurer entered into a Consent Order with the Department and was fined $250,000. The Consent Order also required the insurer to provide the Department with information about the insurer’s other contracted TPAs, including their names, license numbers and contracts. This regulatory action underscores the importance for insurers to work with licensed TPAs and conduct statutorily required audits of TPAs to ensure their TPA business partners are licensed and compliant. A Florida-based insurer recently entered into a Consent Order with
    Read More